T4a laryngeal cancer survival: Retrospective institutional analysis and systematic review

Laryngoscope

Volumn 124, Issue 7, 2014, Pages 1618-1623

  Francis, Evana ^a,b   Matar, Nayla ^a,b   Khoueir, Nadim ^a,b   Nassif, Charbel ^a,b   Farah, Chadi ^a,b   Haddad, Amine ^a,b  

^a SAINT JOSEPH UNIVERSITY   (Lebanon)

^b SAINT JOSEPH UNIVERSITY   (Lebanon)

Author keywords

chemoradiation therapy; chemotherapy; organ preservation; primary total laryngectomy; pT4a laryngeal cancer; radiotherapy; squamous cell carcinoma; survival

Indexed keywords

ADJUVANT CHEMORADIOTHERAPY; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CONFERENCE PAPER; DISEASE FREE SURVIVAL; HUMAN; LARYNGECTOMY; LARYNX CANCER; NECK DISSECTION; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETROSPECTIVE STUDY; SYSTEMATIC REVIEW;

CHEMORADIATION THERAPY; CHEMOTHERAPY; ORGAN PRESERVATION; PRIMARY TOTAL LARYNGECTOMY; PT4A LARYNGEAL CANCER; RADIOTHERAPY; SQUAMOUS CELL CARCINOMA; SURVIVAL;

COMBINED MODALITY THERAPY; HOSPITALS, UNIVERSITY; HUMANS; LARYNGEAL NEOPLASMS; LEBANON; NEOPLASM STAGING; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84903212604     PISSN: 0023852X     EISSN: 15314995     Source Type: Journal    
DOI: 10.1002/lary.24557     Document Type: Conference Paper

References (40)

1. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. The Department of Veterans Affairs Laryngeal Cancer Study Group. N Engl J Med 1991; 324: 1685-1690.
2. Forastiere AA, Goepfert H, Maor M, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 2003; 349: 2091-2098. (Pubitemid 37464533)
3. Maddox PT, Davies L,. Trends in total laryngectomy in the era of organ preservation: a population- based study. Otolaryngol Head Neck Surg 2012; 147: 85-90.
4. Hoffman HT, Porter K, Karnell LH, et al. Laryngeal cancer in the United States: changes in demographics, patterns of care, and survival. Laryngoscope 2006; 116: 1-13. (Pubitemid 44337830)
5. Do L, Puthawala A, Syed N, Azawi S, Williams R, Vora N,. Treatment outcomes of T4 locally advanced head and neck cancers with soft tissue invasion or bone and cartilage invasion. Am J Clin Oncol 2009; 32: 477-482.
6. Semrau S, Waldfahrer F, Lell M, et al. Feasibility, toxicity, and efficacy of short induction chemotherapy of docetaxel plus cisplatin or carboplatin (TP) followed by concurrent chemoradio-therapy for organ preservation in advanced cancer of the hypopharynx, larynx, and base of tongue. Early results. Strahlenther Onkol 2011; 187: 15-22.
7. Wanebo HJ, Rathore R, Chougule P, et al. Selective organ preservation in operable locally advanced head and neck squamous cell carcinomas guided by primary site restaging biopsy: long-term results of two sequential brown university oncology group chemoradiotherapy studies. Ann Surg Oncol 2011; 18: 3479-3485.
8. Furusaka T, Matsuda A, Tanaka A, Matsuda H, Ikeda M,. Superselective intra-arterial chemoradiation therapy for functional laryngeal preservation in advanced squamous cell carcinoma of the glottic larynx. Acta Otolaryngol 2013; 133: 633-640.
9. Canis M, Ihler F, Martin A, Wolff HA, Matthias C, Steiner W,. Organ preservation in T4a laryngeal cancer: is transoral laser microsurgery an option? Eur Arch Otorhinolaryngol 2013; 270: 2719-2727.
10. Stenson KM, Maccracken E, Kunnavakkam R, et al. Chemoradiation for patients with large-volume laryngeal cancers. Head Neck 2012; 34: 1162-1167.
11. Wagner M, Cure J,. Prognostic significance of thyroid or cricoid cartilage invasion in laryngeal or hypopharyngeal cancer treated with organ preserving strategies. Radiat Oncol 2012; 7: 219.
12. Bussu F, Micciche F, Rigante M, et al. Oncologic outcomes in advanced laryngeal squamous cell carcinomas treated with different modalities in a single institution: a retrospective analysis of 65 cases. Head Neck 2012; 34: 573-579.
13. Dziegielewski PT, O'Connell DA, Klein M, et al. Primary total laryngectomy versus organ preservation for T3/T4a laryngeal cancer: a population-based analysis of survival. J Otolaryngol Head Neck Surg 2012; 41 (suppl 1): S56-S64.
14. Jancic S, Zivic M, Radovanovic Z, el al. T4 glottic carcinoma: oncological results and survival rate. HealthMED 2012; 6: 181-187.
15. Jin T, Hu WH, Guo LB, et al. Treatment results and prognostic factors of patients undergoing postoperative radiotherapy for laryngeal squamous cell carcinoma. Chin J Cancer 2011; 30: 482-489.
16. Patel UA, Howell LK,. Local response to chemoradiation in T4 larynx cancer with cartilage invasion. Laryngoscope 2011; 121: 106-110.
17. Gourin CG, Conger BT, Sheils WC, Bilodeau PA, Coleman TA, Porubsky ES,. The effect of treatment on survival in patients with advanced laryngeal carcinoma. Laryngoscope 2009; 119: 1312-1317.
18. Worden FP, Moyer J, Lee JS, et al. Chemoselection as a strategy for organ preservation in patients with T4 laryngeal squamous cell carcinoma with cartilage invasion. Laryngoscope 2009; 119: 1510-1517.
19. Knab BR, Salama JK, Solanki A, el al. Functional organ preservation with definitive chemoradiotherapy for T4 laryngeal squamous cell carcinoma. Ann Oncol 2008; 19: 1650-1654.
20. Laudadio P, Presutti L, Dall'olio D, et al. Supracricoid laryngectomies: long-term oncological and functional results. Acta Otolaryngol 2006; 126: 640-649. (Pubitemid 43995217)
21. Haugen H, Johansson KA, Ejnell H, Edstrom S, Mercke C,. Accelerated radiotherapy for advanced laryngeal cancer. Acta Oncol 2005; 44: 481-489. (Pubitemid 41191781)
22. Ampil FL, Nathan CO, Caldito G, Lian TF, Aarstad RF, Krishnamsetty RM,. Total laryngectomy and postoperative radiotherapy for T4 laryngeal cancer: a 14-year review. Am J Otolaryngol 2004; 25: 88-93. (Pubitemid 38418967)
23. Hall FT, O'Brien CJ, Clifford AR, McNeil EB, Bron L, Jackson MA,. Clinical outcome following total laryngectomy for cancer. ANZ J Surg 2003; 73: 300-305. (Pubitemid 36649280)
24. Parsons JT, Mendenhall WM, Stringer SP, Cassisi N,. T4 laryngeal carcinoma: radiotherapy alone with surgery reserved for salvage. Int J Radiat Oncol Biol Phys 1998; 40: 549-552. (Pubitemid 28104223)
25. Santos CR, Kowalski LP, Magrin J, et al. Prognostic factors in supraglottic carcinoma patients treated by surgery or radiotherapy. Ann Otol Rhinol Laryngol 1998; 107: 697-702. (Pubitemid 28371391)
26. Finizia C, Geterud A, Holmberg E,. Advanced laryngeal cancer T3-T4 in Sweden: a retrospective study 1986-1990. Survival and locoregional control related to treatment. Acta Otolaryngol 1996; 116: 906-912. (Pubitemid 26408254)
27. Gallo O, Boddi V, Bottai GV, Franchi A, Storchi OF,. Prognostic significance of clinically false positive cervical lymph nodes in patients with laryngeal carcinoma. Cancer 1995; 75: 1077-1083.
28. Karim AB, Kralendonk JH, Njo KH, Tierie AH, Hasman A,. Radiation therapy for advanced (T3T4N0-N3M0) laryngeal carcinoma: the need for a change of strategy: a radiotherapeutic viewpoint. Int J Radiat Oncol Biol Phys 1987; 13: 1625-1633. (Pubitemid 17160124)
29. Croll GA, Gerritsen GJ, Tiwari RM, Snow GB,. Primary radiotherapy with surgery in reserve for advanced laryngeal carcinoma. Results and complications. Eur J Surg Oncol 1989; 15: 350-356. (Pubitemid 19212518)
30. Mirimanoff RO, Wang CC, Doppke KP,. Combined surgery and postoperative radiation therapy for advanced laryngeal and hypopharyngeal carcinomas. Int J Radiat Oncol Biol Phys 1985; 11: 499-504. (Pubitemid 15124065)
31. Harwood AR, Beale FA, Cummings BJ, Keane TJ, Payne D, Rider WD,. T4NOMO glottic cancer: an analysis of dose-time volume factors. Int J Radiat Oncol Biol Phys 1981; 7: 1507-1512. (Pubitemid 12203090)
32. Lefebvre JL,. Larynx preservation. Curr Opin Oncol 2012; 24: 218-222.
33. Olsen KD,. Reexamining the treatment of advanced laryngeal cancer. Head Neck 2010; 32: 1-7.
34. Chen AY, Fedewa S, Zhu J,. Temporal trends in the treatment of early- and advanced-stage laryngeal cancer in the United States, 1985-2007. Arch Otolaryngol Head Neck Surg 2011; 137: 1017-1024.
35. Chen AY, Halpern M,. Factors predictive of survival in advanced laryngeal cancer. Arch Otolaryngol Head Neck Surg 2007; 133: 1270-1276. (Pubitemid 350294258)
36. Pfister DG, Ang KK, Brizel DM, et al. Head and neck cancers, version 2.2013. Featured updates to the NCCN guidelines. J Natl Compr Canc Netw 2013; 11: 917-923.
37. Laccourreye O, Malinvaud D, Holsinger FC, Consoli S, Menard M, Bonfils P,. Trade-off between survival and laryngeal preservation in advanced laryngeal cancer: the otorhinolaryngology patient's perspective. Ann Otol Rhinol Laryngol 2012; 121: 570-575.
38. Caudell JJ, Carroll WR, Spencer SA, Bonner JA,. Examination of laryngoesophageal dysfunction-free survival as an endpoint in nonsurgical treatment of squamous cell carcinomas of the larynx and hypopharynx. Cancer 2011; 117: 4447-4451.
39. Woodard TD, Oplatek A, Petruzzelli GJ,. Life after total laryngectomy: a measure of long-term survival, function, and quality of life. Arch Otolaryngol Head Neck Surg 2007; 133: 526-532. (Pubitemid 46974880)
40. Sanabria A, Domenge C, D'Cruz A, Kowalski LP,. Organ preservation protocols in developing countries. Curr Opin Otolaryngol Head Neck Surg 2010; 18: 83-88.